The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: Proposed mechanism for soluble HLA release in transplant rejection

Human Immunology

Volumn 59, Issue 7, 1998, Pages 426-434

  Devito Haynes, L D ^a   Demaria, S ^b   Bushkin, Y ^b   Burlingham, W J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; HLA ANTIGEN CLASS 1; METALLOPROTEINASE;

ANTIGEN EXPRESSION; ARTICLE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IMMUNOSTIMULATION; PRIORITY JOURNAL;

BETA 2-MICROGLOBULIN; CELL-FREE SYSTEM; CELLS, CULTURED; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PHENYLALANINE; POKEWEED MITOGENS; SOLUBILITY; THIOPHENES; TIME FACTORS;

EID: 0031851538     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00032-9     Document Type: Article

References (48)

1. Ploegh H.L., Orr H.T., Strominger J.L. Major histocompatibility antigens The human (HLA-A, B, C) and murine (H-2K, H-2D) class I molecules . Cell. 24:1981;287.
2. Bushkin Y., Posnett D.N., Pernis B., Wang C.Y. A new HLA-linked T cell membrane molecule, related to the β chain of the clonotypic receptor, is associated with T3. J Exp Med. 164:1986;458.
3. 2-microglobulin. J Exp Med. 171:1990;1431.
4. Madrigal J.A., Belich M.P., Benjamin R.J., Little A.M., Hildebrand W.H., Mann D.L., Parham P. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells. J Exp Med. 174:1991;1085.
5. 2m-free MHC class I molecules induced on activated T cells. Cell Immunol. 142:1992;103.
6. Matko J., Bushkin Y., Wei T., Edidin M. Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. J Immunol. 152:1994;3353.
7. Chakrabarti A., Matko J., Rahman N.A., Barisas B.G., Edidin M. Self-association of class I major histocompatibility complex molecules in liposome and cell surface membranes. Biochemistry. 31:1992;7182.
8. 2microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem. 269:1994;6689.
9. Haga J.A., She J.X., Kao K.J. Biochemical characterization of 39-kDa class I histocompatibility antigen in plasma a secretable membrane protein derived from transmembrane domain deletion . J Biol Chem. 266:1991;3695.
10. Allison J.P., Pellegrino M.A., Ferrone S., Callahan G.I.V., Reisfeld R.A. Biologic and chemical characterization of HLA antigens in human serum. J Immunol. 118:1977;1004.
11. Krangel M.S. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med. 163:1986;1173.
12. Zavazava N., Leimenstoll G., Mueller-Ruchholtz W. Measurement of soluble MHC class I molecules in renal graft patients a noninvasive allograft monitor . J Clin Lab Anal. 4:1990;426.
13. DeVito-Haynes L.D., Jankowska-Gan E., Sollinger H.W., Knechtle S.J., Burlingham W.J. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol. 40:1994;191.
14. DeVito-Haynes L.D., Jankowska-Gan E., Heisey D., Jutte N.H.P.M., Balk A.H.M.M., Weimar W., Claas F.H.J., Warner T.F.C., Mentzer R.M., Love R.B., Burlingham W.J. Donor-derived HLA class I proteins in the serum of heart transplant recipients. J Heart Lung Transplant. 15:1996;1012.
15. DeVito-Haynes L.D., Jankowska-Gan E., Heisey D.M., Cornwell R.D., Meyer K.C., Love R.B., Burlingham W.J. Soluble HLA class I in epithelial lining fluid of lung transplants associations with graft outcome . Hum Immunol. 52:1997;95.
16. Billingham M.E., Cary N.R.B., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection heart rejection study group . J Heart Lung Transplant. 9:1990;587.
17. Stam N.J., Spits H., Ploegh H.L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol. 137:1986;2299.
18. Tanabe M., Sekimata M., Ferrone S., Takiguchi M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reactive with the HLA Class I α3 domain. J Immunol. 148:1992;3202.
19. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., Ziegler A. Production of monoclonal antibodies to group A erythrocyes, HLA and other human cell surface antigens - new tools for genetic analysis. Cell. 14:1978;9.
20. DeVito L.D., Sollinger H.W., Burlingham W.J. Adsorption of cytotoxic anti-HLA antibodies with HLA class I immunosorbant beads. Transplantation. 49:1990;925.
21. Hiraki D.D., See-Tho K., Filvaroff E., Krishnaswamy S., de Bello W., Taidi-Laskowski B., Grumet F.C. Bioengineered soluble HLA-B7 Genesis, characterization, and occurrence of dimerization . Hum Immunol. 40:1994;235.
22. Davies B., Brown P.D., East N., Crimmin M.J., Balkwill F.R. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res. 53:1993;2087.
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
24. Little A.M., Nobner E., Parham P. Dissociation of β2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail. J Immunol. 154:1995;5205.
25. Zeevi A., Fung J., Zerbe T.R., Kaufman C., Rabin B.S., Griffith B.P., Hardesty R.L., Duquesnoy R.J. Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation. 41:1986;620.
26. Rabinowich H., Zeevi A., Yousem S.A., Paradis I.L., Dauber J.H., Kormos R., Hardesty R.L., Griffith B.P., Duquesnoy R.J. Alloreactivity of lung biopsy and bronchoalveolar lavage-derived lymphocytes from pulmonary transplant patients correlation with acute rejection and bronchiolitis obliterans . Clin Transplant. 4:1990;376.
27. Sell K.W., Tadros T., Wang Y.C. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation. J Heart Transplant. 7:1988;407.
28. Herskowitz A., Ahmed-Ansari A., Neumann D.A., Beschorner W.E., Rose N.R., Soule L.M., Burek C.L., Sell K.W., Baughman K.L. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis a nonhistologic marker of myocarditis . J Am Coll Cardiol. 15:1990;624.
29. Wang Y.C., Herskowitz A., Gu L.B., Kanter K., Lattouf O., Sell K.W., Ahmed-Ansari A. Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro. Hum Immunol. 31:1991;123.
30. Zhai Y., Knechtle S.J. Two distinct forms of soluble MHC class I molecules synthesized by different mechanisms in normal rat cells in vitro. Hum Immunol. 59:1998;404.
31. Elliott T., Cerundolo V., Elvin J., Townsend A. Peptide-induced conformational change of the class I heavy chain. Nature. 351:1991;402.
32. Matsui M., Hioe C.E., Frelinger J.A. Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci USA. 90:1993;674.
33. 2-microglobulin complexes requires specific peptides . J Biol Chem. 267:1992;5451.
34. 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound. J Immunol. 149:1992;1896.
35. Keenan R.J., Uknis M.E., Pham S.M., Spichty K., Duquesnoy R.J., Griffith B.P., Zeevi A. Mitogen responses of lymphocytes from lung transplant recipients - correlation with rejection and infection. Transplantation. 54:1992;241.
36. d in animals transgenic for its soluble analog. Hum Immunol. 52:1997;82.
37. Grumet F.C., Krishnaswamy S., See-Tho K., Filvaroff E., Hiraki D.D. Soluble form of an HLA-B7 class I antigen specifically suppresses humoral alloimmunization. Hum Immunol. 40:1994;228.
38. Graeb C., Scherer M.N., Knechtle S.J., Geissler E.K. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules. Hum Immunol. 59:1998;415.
39. Suciu-Foca N., Reed E., D'Agati V.D., Ho E., Cohen D.J., Benvenisty A., McCabe R., Brensilver J., King D.W., Hardy M.A. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation. 51:1991;593.
40. Krensky A.M., Clayberger C. HLA-derived peptides as novel immunotherapeutics. Clin Immunol Immunopathol. 75:1995;112.
41. Puppo F., Scudeletti M., Indiveri F., Ferrone S. Serum HLA class I antigens markers and modulators of an immune response? Immunol Today. 16:1995;124.
42. Buelow R., Burlingham W.J., Clayberger C. Immunomodulation by soluble HLA class I. Transplantation. 59:1995;649.
43. 2m. J Clin Invest. 98:1996;2746.
44. Zavazava N., Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med. 2:1996;1005.
45. Benham A.M., Sawyer G.J., Fabre J.W. Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts. Transplantation. 59:1995;1028.
46. Watschinger B., Gallon L., Carpenter C.B., Sayegh M. Mechanisms of allo-recognition Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells . Transplantation. 57:1994;572.
47. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-γ receptor. Science. 259:1993;1742.
48. Ciubotariu R., Liu Z., Colovai A., Ho E., Itescu S., Ravalli S., Hardy M.A., Cortesini R., Rose E.A., Suciu-Foca N. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest. 101:1998;398.